Vanguard Global Advisers, LLC
Position in IMDX — Insight Molecular Diagnostics Inc.
CIK 1811242
MALVERN, PA
Position in IMDX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$18,942
New position
Shares Held
5,775
first reported quarter
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Vanguard Global Advisers, LLC holds $1,197,338,329 across 38 Diagnostics & Research names. IMDX ranks #34 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
822,047 | $404,060,761 | |
| 2 | DHR |
Danaher Corp /De/
|
1,376,322 | $260,950,651 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
174,862 | $98,253,209 | |
| 4 | A |
Agilent Technologies, Inc.
|
618,952 | $70,548,148 | |
| 5 | WAT |
Waters Corp /De/
|
214,292 | $63,816,157 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
371,124 | $63,291,486 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
44,483 | $56,101,959 | |
| 8 | LH |
Labcorp Holdings Inc.
|
181,982 | $48,554,617 |
All Filings in IMDX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,942 | 5,775 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||